Medicare’s proposed pilot to cover GLP-1 drugs like Wegovy and Zepbound has been delayed.
Trump’s Plan to Expand Access to Weight-Loss Drugs Just Hit a Major Roadblock
You Might Also Like
Todd Snyder: Own the Experience, Own the Brand
Todd Snyder’s aim from the outset has been to control his customer experience.
26 Ways to Keep Technology Flexible as Your Business Evolves
Smart entrepreneurs build tech stacks that bend, not break.
Brace yourself for a flood of patches in all of your tech gadgets
On April 7, Anthropic unveiled its most powerful AI model to date. Mythos, it said, will help companies discover vulnerabilities…
SpaceX doubles down on AI with its potential $60 billion Cursor buy
SpaceX still has deep roots in the rocket business, but the Elon Musk-owned company is doubling down on artificial intelligence…
